BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18024510)

  • 1. Efavirenz accelerates HIV-1 reverse transcriptase ribonuclease H cleavage, leading to diminished zidovudine excision.
    Radzio J; Sluis-Cremer N
    Mol Pharmacol; 2008 Feb; 73(2):601-6. PubMed ID: 18024510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway.
    Álvarez M; Nevot M; Mendieta J; Martínez MA; Menéndez-Arias L
    J Biol Chem; 2018 Feb; 293(7):2247-2259. PubMed ID: 29275329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3'-azido-3'-deoxythymidine through both RNase H-dependent and -independent mechanisms.
    Ehteshami M; Beilhartz GL; Scarth BJ; Tchesnokov EP; McCormick S; Wynhoven B; Harrigan PR; Götte M
    J Biol Chem; 2008 Aug; 283(32):22222-32. PubMed ID: 18547911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.
    Brehm JH; Scott Y; Koontz DL; Perry S; Hammer S; Katzenstein D; Mellors JW; Sluis-Cremer N;
    PLoS One; 2012; 7(2):e31558. PubMed ID: 22363673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors.
    Schneider A; Corona A; Spöring I; Jordan M; Buchholz B; Maccioni E; Di Santo R; Bodem J; Tramontano E; Wöhrl BM
    Nucleic Acids Res; 2016 Mar; 44(5):2310-22. PubMed ID: 26850643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms by which the G333D mutation in human immunodeficiency virus type 1 Reverse transcriptase facilitates dual resistance to zidovudine and lamivudine.
    Zelina S; Sheen CW; Radzio J; Mellors JW; Sluis-Cremer N
    Antimicrob Agents Chemother; 2008 Jan; 52(1):157-63. PubMed ID: 17967907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of HIV-1 resistance to 3'-azido-2',3'-dideoxyguanosine.
    Meteer JD; Schinazi RF; Mellors JW; Sluis-Cremer N
    Antiviral Res; 2014 Jan; 101():62-7. PubMed ID: 24211331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC.
    Davis CA; Parniak MA; Hughes SH
    Virology; 2011 Oct; 419(2):64-71. PubMed ID: 21907380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism by which a glutamine to leucine substitution at residue 509 in the ribonuclease H domain of HIV-1 reverse transcriptase confers zidovudine resistance.
    Brehm JH; Mellors JW; Sluis-Cremer N
    Biochemistry; 2008 Dec; 47(52):14020-7. PubMed ID: 19067547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
    Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2002 Sep; 76(18):9143-51. PubMed ID: 12186898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subunit-specific mutational analysis of residue N348 in HIV-1 reverse transcriptase.
    Radzio J; Sluis-Cremer N
    Retrovirology; 2011 Aug; 8():69. PubMed ID: 21859446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2001 May; 75(10):4832-42. PubMed ID: 11312355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.
    Yap SH; Sheen CW; Fahey J; Zanin M; Tyssen D; Lima VD; Wynhoven B; Kuiper M; Sluis-Cremer N; Harrigan PR; Tachedjian G
    PLoS Med; 2007 Dec; 4(12):e335. PubMed ID: 18052601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efavirenz stimulates HIV-1 reverse transcriptase RNase H activity by a mechanism involving increased substrate binding and secondary cleavage activity.
    Muchiri JM; Li D; Dykes C; Bambara RA
    Biochemistry; 2013 Jul; 52(29):4981-90. PubMed ID: 23806074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
    Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
    Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6.
    Corona A; Meleddu R; Esposito F; Distinto S; Bianco G; Masaoka T; Maccioni E; Menéndez-Arias L; Alcaro S; Le Grice SF; Tramontano E
    PLoS One; 2016; 11(1):e0147225. PubMed ID: 26800261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective interaction of the human immunodeficiency virus type 1 reverse transcriptase nonnucleoside inhibitor efavirenz and its thio-substituted analog with different enzyme-substrate complexes.
    Maga G; Ubiali D; Salvetti R; Pregnolato M; Spadari S
    Antimicrob Agents Chemother; 2000 May; 44(5):1186-94. PubMed ID: 10770750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.
    Miranda LR; Götte M; Liang F; Kuritzkes DR
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2648-56. PubMed ID: 15980332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role of template cleavage in reduced excision of chain-terminating nucleotides by human immunodeficiency virus type 1 reverse transcriptase containing the M184V mutation.
    Acosta-Hoyos AJ; Matsuura SE; Meyer PR; Scott WA
    J Virol; 2012 May; 86(9):5122-33. PubMed ID: 22379084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.